Purpose/Objective: Modern radiotherapy techniques such as IMRT and VMAT allow physicians to spare organs at risk of radiotherapy damage thereby improving quality of life (QoL) amongst survivors. In patients undergoing radical radiotherapy (RRT) for head and neck cancer, dose to SWOAR is increasingly being recognised as a determinant of QoL and long-term function such as dysphagia, regurgitation and tube dependency. Therefore, it has been proposed that limiting dose to SWOAR would be a desirable goal. However, there is no data on dosimetry of SWOAR during treatment or whether changes are potentially due to tumour response or inflammation thereby, supporting a strategy of enforcing strict dose constraints. This study aimed to document dosimetry of SWOAR using midway planning CT scan, whilst applying the original treatment plan as well as an adaptive plan generated de novo.
Conclusions:
This study showed delineation and evaluation of dose to SWOAR at the initial planning stage was a reasonably good estimation of expected dose throughout treatment. Therefore applying treatment planning constraints at the outset, would be a reasonable strategy to reduce dose to SWOAR. Our data reveals there may be some concern over the variance in dosimetry to the cricopharyngeal muscle, superior inferior pharyngeal constrictor muscle and esophageal inlet muscle over the course of RRT treatment. Purpose/Objective: Respiratory motion limits the efficacy of intensity modulated radiation therapy (IMRT) as larger treatment fields are required to prevent geographic misses. With respiratory-gated RT, the irradiated lung volume is reduced by the selection of beam-on-phase in the respiration cycle (i.e. the gating window). The aim of this study is to compare the lung dosimetric parameters at RT gated around 40%-60% and 30%-70% windows of a respiratory cycle around endexpiration. Materials and Methods: Thirteen NSCLC patients who underwent fourdimensional computed tomography (4DCT) simulations were studied retrospectively. Patients were CT-scanned under normal respiration. Patients with tumor motion greater than 5 mm were selected for this study. For each patient, two CT datasets were reconstructed (40%-60% gating window and 30%-70% gating window). Planning target volumes, heart, esophagus, and spinal cord were contoured in the 40%-60% and the 30%-70% gating window CT data set. The lungs were contoured separately on both CT data sets. In the lung-contouring process, a Varian Eclipse treatment planning system automatic contouring tool was employed. Default CT threshold values were used. The lung contours were visually verified on each slice. Intensity-modulated radiotherapy plans were generated on the CT data sets with 40%-60% and 30%-70% gating window and doses were recomputed. The evaluation metric was based on dose indices and volume indices for targets and critical structures. Statistical tests were used to establish the significance of the differences between the different gating windows to find the optimal setting of the gating window of a respiratory cycle around end-expiration. Results: For all patients, homogeneity indices were similar for 30%-70% and 40%-60% IMRT plans. PTV dose uniformity, as indicated by (D 2% -D 98% )/D 50% , were all within 0.15 between 40%-60% and 30%-70% gating phases for 13 patients. The average mean lung dose was 3.1 Gy in the 40%-60% and 30%-70% gating phases. The V 20 at 40%-60% and 30%-70% gating windows were 4.5% and 4.3%, respectively; The V 10 at 40%-60% and 30%-70% gating windows were 8.1% and 7.9%, respectively. The V 5 at 40%-60% and 30%-70% gating windows were 14.3% and 14.5%, respectively. The difference in dosimetric parameters of lung obtained with 40%-60% and 30%-70% gating windows were not statistically different. The average mean heart dose was 2.2 Gy in the 40%-60% and 30%-70% gating phases. The average mean esophagus dose was 2.4 Gy for 40%-60% plans and 2.5 Gy for 30%-70% plans. The average D 1% cord dose was 10.4 Gy for 40%-60% plans and 10.8 Gy for 30%-70% plans. All the toxicity parameters of the organs at risk did not show any statistically significant correlation in both 40%-60% and 30%-70% plans. Conclusions: We found that lung dosimetric parameters and all the toxicity parameters of the organs at risk were comparable with gating was around 40%-60% or 30%-70% phases. Given that shorter treatment time in the 30%-70% gating windows, it may be more beneficial to deliver the therapy using this parameter. Purpose/Objective: The use of a breath hold technique enables a significant decrease of the dose to the heart as well as the left anterior descending coronary artery (LAD). Radiation dose to the heart and LAD (i.e. the OARs) could result in long-term cardiac toxicity. A further decrease of the dose to both structures might be possible using proton therapy. We, therefore, examined whether the use of proton therapy (when compared to an IMRT technique) could eventually lead to a further decrease of the dose to the OARs. Materials and Methods: Twenty patients with left-sided breast cancer referred for radiotherapy after breast conserving surgery were included in our study. All patients underwent a free breathing (FB) and a breath hold (BH) 3D-CT-scan in supine treatment position. CTV and heart and LAD were delineated by one observer. PTV was composed according to institutional guidelines. All plans had to meet the criterion that 97% of PTV was covered by the 95% isodose (V95%). The prescribed dose was 42.56 Gy. nd ESTRO Forum 2013 For the IMRT technique, forty percent of the dose was given with two open fields, and sixty percent with four inversely planned 'Step-andShoot' IMRT fields. For proton therapy a spot scanning technique with intensity modulation (IMPT) was used with a three beam set-up. In all plans the gantry angles were 345° (-15°), 27° and 75°. The spots were placed in such way that no spot was more than 0.2 cm outside the PTV and spots separated by 8 mm distance in the plane perpendicular to the beam direction. The spot layers were positioned 5 mm apart from each other. For both techniques it was attempted to produce the most optimal plan in reducing the dose to the OARs as much as possible. All plans were adapted to the individual target volumes and OARs, using trialand-error. We compared IMRT and IMPT based on a FB as well as on a BH CT-scan for all patients. Results: In all plans coverage of the PTV was adequate. Furthermore, the dose to the OARs was decreased in all IMPT plans compared to IMRT plans. There was only a small difference between BH and FB in the IMPT plans (see the table). 
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